Supplementary Tables 1 - 4 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Feng Xu,Jing Liu,Di Liu,Biao Liu,Min Wang,Zhiyuan Hu,Xuemei Du,Li Tang,Fuchu He

DOI: https://doi.org/10.1158/0008-5472.22399923.v1

2023-01-01

Abstract:<p>PDF file - 71KB, Supplementary Table 1 Characteristics of 7 types of cancer patient in cancer survey array. Supplementary Table 2 Characteristics of patient in melanoma RNA chip. Supplementary Table 3 Characteristics of patient in melanoma IHC chip. Supplementary Table 4. Characteristics of patient in flow cytometry analysis.</p>

Supplementary Data from Tumor-associated Lymphatic Endothelial Cells Promote Lymphatic Metastasis by Highly Expressing and Secreting SEMA4C

Jun-Cheng Wei,Jie Yang,Dan Liu,Ming-Fu Wu,Long Qiao,Jun-Nai Wang,Quan-Fu Ma,Zhen Zeng,Shuang-Mei Ye,En-Song Guo,Xue-Feng Jiang,Lan-Ying You,Ying Chen,Li Zhou,Xiao-Yuan Huang,Tao Zhu,Li Meng,Jian-Feng Zhou,Zuo-Hua Feng,Ding Ma,Qing-Lei Gao

DOI: https://doi.org/10.1158/1078-0432.22466258.v1

2023-01-01

Abstract:The "Supplemental Data" contains supplementary methods,supplementary table 1 and supplementary figures1-19.1.Supplementary methods: Antibodies and Reagents, Primary culture of LECs, Immunomagnetic isolation of LECs, Expressing human recombinant sSEMA4C protein, Liquid chromatography - Electrospray ionization tandem MS (LC-ESI/MS), Migration assay, Wound healing assay, Cell proliferation assay, Primers sequences; 2.Supplementary Table 1: the Patient characteristics; 3.Supplementary Figure 1: the Authentication of LECs; 4.Supplementary Figure 2: the Evaluation of LCM-isolated LECs using RNA markers; 5. Supplementary Figure 3 : SEMA4C expresses on lymphatic vessels; 6.Supplementary Figure 4 : Nano-LC-ESI-MS/MS spectrum of a single charged deglycosylated glycopeptide from the culture supernatants of tumor LECs; 7. Supplementary Figure 5 :sSEMA4C binds to tumor cells and LECs; 8.Supplementary Figure 6: sSEMA4C promotes the migration and proliferation of tumor cells; 9.Supplementary Figure 7: SEMA4C promotes LECs function in vitro; 10.Supplementary Figure 8 : targeting SEMA4C inhibits LECs function in vitro; 11.Supplementary Figure 9 : the growth of the tumors; 12.Supplementary Figure 10 : Knock-down of PlexinBs; 13.Supplementary Figure 11 : Blocking ERBB2 or PlexinB2 inhibits SEMA4C-induced lymphangiogenesis in vitro; 14.Supplementary Figure 12 : LEC was stimulated by VEGF-C and sSEMA4C; 15.Supplementary Figure 13 : sSEMA4C activates MET and RHOA in tumor cells; 16.Supplementary Figure 14 : blocking MET or PlexinB2 inhibits SEMA4C-induced migration and proliferation of tumor cells; 17.Supplementary Figure 15 : cells treated with sSEMA4C; 18.Supplementary Figure 16 : targeting RHOA inhibits SEMA4C-induced lymphangiogenesis in vitro and in vivo; 19.Supplementary Figure 17 : targeting RHOA inhibits SEMA4C-induced migration of tumor cells; 20.Supplementary Figure 18 : 3 days after inoculation with tumour cells, the mice were treated with Lapatinib, K252a ,C3 toxin, Fasudil, Y27632 , sSEMA4C and PBS control solution, the size of tumor was measured; 21.Supplementary Figure 19: 3 days after inoculation with tumour cells, the mice were treated with Lapatinib, K252a ,C3 toxin, Fasudil, Y27632 , sSEMA4C and PBS control solution, the average number of positive lymph node in each mice were calculated.

Supplementary Figure 1 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Supplementary Figure 4 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Supplementary Figure 3 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Supplementary Figure 6 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Supplementary Figure 7 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Supplementary Figure 2 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Tables 1 - 4 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Supplementary Figure.2 from the Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation

Supplementary Data from Tumor-associated Lymphatic Endothelial Cells Promote Lymphatic Metastasis by Highly Expressing and Secreting SEMA4C

Supplementary Figure Legends 1-8 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Supplementary Figure 4 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Supplementary Figure 5 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Supplementary Figure 6 from A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure 1 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Supplementary Figure Legends from EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance

Supplementary Figure 8 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Supplementary Figure 7 from LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response

Supplementary Figure 2 from A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis